SGLT2 Inhibitors

SGLT2 inhibitors are a class of prescription medications used to treat Type 2 diabetes, heart failure, and chronic kidney disease by blocking glucose reabsorption in the kidneys, causing excess sugar to be excreted through urine. Common, effective drugs include empagliflozin, dapagliflozin, and canagliflozin, which also help lower blood pressure, reduce weight, and protect heart and kidney function